Investor's Business Daily on MSN1h
AstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped.
AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
precisionmedicineonline1h
AstraZeneca Optimistic About Phase III Capivasertib Data in 2025, Reports Strong Q4 Product Growth
If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.
The Nation Newspaper5h
How I survived breast cancer 27 years ago – Betty Akeredolu
In commemoration of World Cancer Day 2025, themed “United by Unique,” Betty Anyanwu-Akeredolu, widow of former Ondo State ...
Targeted Oncology6h
Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia
In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan ...
AstraZeneca reports better than expected profit on higher cancer drug sales
Earnings per share excluding some items surged to $2.09, Astra said Thursday, higher than the $2.04 estimated by analysts ...
Science Daily9h
Researchers find improved method for treating rare, aggressive, pregnancy-related cancer
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.
‘I have no idea if I’ll be dead next week,’ says mum, 38 as she plans to mark kids’ life milestones after her death
A MUM-of-two diagnosed with terminal breast cancer after her second round of IVF has written cards for both of her children ...
Hosted on MSN12h
How diet, early detection helped me beat breast cancer — Betty Akeredolu
Akeredolu, wife of the late former governor of Ondo State, Rotimi Akeredolu, has opened up about her 27-year battle with ...